Published in Infect Immun on November 01, 1974
Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. Clin Exp Immunol (1978) 2.29
Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun (1977) 2.23
Activation and binding of C3 by Candida albicans. Infect Immun (1987) 1.17
A functional comparison of blood and gingival inflammatory polymorphonuclear leucocytes in man. Clin Exp Immunol (1977) 1.16
Hepatic clearance of Candida albicans in rats. Infect Immun (1976) 1.10
Discrepancy in assessment of phagosome-lysosome fusion with two lysosomal markers in murine macrophages infected with Candida albicans. Infect Immun (1987) 1.05
The role of complement and antibody in opsonization and intracellular killing of Candida albicans. Clin Exp Immunol (1984) 1.03
Quantitative analysis of opsonophagocytosis and of killing of Candida albicans by human peripheral blood leukocytes by using flow cytometry. J Clin Microbiol (1991) 1.02
Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes. J Clin Microbiol (1992) 1.00
The role of Fc and C3b receptors in phagocytosis by inflammatory polymorphonuclear leucocytes in man. Immunology (1977) 0.94
Alterations in lung macrophage antimicrobial activity associated with viral pneumonia. Infect Immun (1979) 0.93
Macrophage dysfunction after burn injury. Infect Immun (1979) 0.88
Biochemical and functional alterations in macrophages after thermal injury. Infect Immun (1984) 0.83
Influence of cadmium on the phagocytic and microbicidal activity of murine peritoneal macrophages, pulmonary alveolar macrophages, and polymorphonuclear neutrophils. Infect Immun (1978) 0.81
Alteration of the structure and function of guinea pig peritoneal macrophages by a soybean oil emulsion. Am J Pathol (1979) 0.79
Testing monocyte function. Br Med J (1978) 0.75
Effects of mercury on human polymorphonuclear leukocyte function in vitro. Am J Pathol (1988) 0.75
Interaction of Candida albicans with human leukocytes and serum. J Bacteriol (1969) 9.19
Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest (1967) 9.01
Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc (1972) 4.60
A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med (1970) 4.42
Measurement of candidacidal activity of specific leukocyte types in mixed cell populations I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils. Infect Immun (1970) 3.12
Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med (1968) 2.11
A simple rapid micromethod for detecting chronic granulomatous disease of childhood. J Lab Clin Med (1970) 1.81
Molecular basis of gouty inflammation: interaction of monosodium urate crystals with lysosomes and liposomes. Nat New Biol (1972) 1.59
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J Immunol (1971) 1.51
Phagocytosis, with particular reference to encapsulated bacteria. Bacteriol Rev (1960) 1.37
[The Alius-Grignaschi anomaly: the hereditary constitutional peroxidase defect of the neutrophils and monocytes]. Blut (1966) 1.20
A method for quantitation of human leukocyte adhesion to glass. Proc Soc Exp Biol Med (1972) 1.14
Microbicidal activity of peroxidaseless chicken heterophile leukocytes. Infect Immun (1972) 1.10
HUMORAL FACTORS IN CELLULAR RESISTANCE. II. THE ROLE OF COMPLEMENT AND PROPERDIN IN PHAGOCYTOSIS AND CYTOPEPSIS BY NORMAL AND "IMMUNE" MACROPHAGES. J Immunol (1964) 1.10
Correlation between antimicrobial activity and peroxidase content of leukocytes. Nature (1973) 1.10
Microbicidal activity of human eosinophils. J Reticuloendothel Soc (1972) 1.07
Job's syndrome--a variant of chronic granulomatous disease. Report of a case. J Pediatr (1969) 0.99
Phagocytosis of Candida albicans by rabbit neutrophils. Sabouraudia (1973) 0.88
Serum and cellular factor involvement in nitroblue tetrazolium (NBT) reduction by human neutrophils. Klin Wochenschr (1973) 0.84
Conflicting results on metabolic studies of leukocytes from patients with osteogenesis inperfecta: notes on NBT test. J Pediatr (1972) 0.82
Bactericidal function of polymorphonuclear leukocytes. Arch Environ Health (1969) 0.82
Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93
The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93
Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83
Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Arch Toxicol (1990) 1.59
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51
Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature (1978) 1.44
Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42
Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42
Peroxidaseless chicken leukocytes: isolation and characterization of antibacterial granules. J Infect Dis (1973) 1.39
Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.36
Leukocytes and prostaglandins in acute inflammation. Experientia (1974) 1.35
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28
Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24
Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci (1988) 1.17
Biodistribution of mild analgesics. Br J Clin Pharmacol (1980) 1.12
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12
Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia (1975) 1.11
Microbicidal activity of peroxidaseless chicken heterophile leukocytes. Infect Immun (1972) 1.10
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol (1999) 1.10
Correlation between antimicrobial activity and peroxidase content of leukocytes. Nature (1973) 1.10
Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth (1993) 1.10
Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2000) 1.08
Prostaglandin release from macrophages: an assay system for anti-inflammatory drugs in vitro. Agents Actions (1977) 1.08
Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations. Agents Actions Suppl (1986) 1.07
Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions (1990) 1.06
Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol (1994) 1.05
Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs (1991) 1.04
Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol (1992) 1.02
Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01
Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol (1988) 1.01
Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol (1998) 1.00
Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun (2000) 0.99
Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci (2000) 0.99
Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo. Prostaglandins (1991) 0.99
Non-acidic pyrazoles: inhibition of prostaglandin production, carrageenan oedema and yeast fever. Agents Actions (1983) 0.98
Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain (1995) 0.98
Role of the parietal cell in gastric damage induced by aspirin and related drugs: implications for safer therapy. Med J Aust (1976) 0.97
How aspirin might work: a pharmacokinetic approach. Agents Actions (1974) 0.97
Non-steroid anti-inflammatory drugs: influence of extra-cellular pH on biodistribution and pharmacological effects. Biochem Pharmacol (1978) 0.95
[Treatment of tension-type headache. Recommendation of the German Migraine and Headache Society]. Schmerz (1998) 0.95
Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol (1989) 0.95
Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. Eur J Clin Pharmacol (1990) 0.94
Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration. Clin Pharmacol Ther (1999) 0.94
High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. J Chromatogr (1989) 0.94
Ibuprofen as an over-the-counter drug: is there a risk for renal injury? Clin Nephrol (1993) 0.94
Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci (2001) 0.93
Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology. Aliment Pharmacol Ther (2004) 0.93
Stereoselective high-performance liquid chromatographic determination of flurbiprofen in human plasma. J Chromatogr (1992) 0.93
Mechanisms of action of anti-inflammatory drugs. Gen Pharmacol (1976) 0.93
Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J (2000) 0.92
Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. Neuroreport (1997) 0.92
Identification and characterization of inhibitors of peptido-leukotriene-synthesis from Petasites hybridus. Planta Med (1994) 0.92
Mode of antinociceptive action of flupirtine in the rat. Br J Pharmacol (1989) 0.91
Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett (1998) 0.90
Carbocyanine dyes stain the sarcoplasmic reticulum of beating heart cells. Exp Cell Res (1980) 0.90
Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res (1998) 0.89
Pharmacological differences between R(-)- and S(+)-ibuprofen. Agents Actions (1989) 0.89
Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration. Antimicrob Agents Chemother (1997) 0.89
Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology (1999) 0.88
Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br J Pharmacol (1997) 0.88
Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia. Inflamm Res (2001) 0.88
Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen. Mol Pharmacol (1997) 0.88
Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium. Eur J Biochem (2000) 0.87
Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen. Br J Pharmacol (1998) 0.87
Differential effects of dipyrone, ibuprofen, and paracetamol on experimentally induced pain in man. Agents Actions (1992) 0.87
Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology (1997) 0.87
Parietal cells of the stomach trap salicylates during absorption. Biochem Pharmacol (1977) 0.87
Controversies in COX-2 selective inhibition. J Rheumatol (2002) 0.86
Variability of inversion of (R)-flurbiprofen in different species. J Pharm Sci (1992) 0.86
Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral alpha 1-acid glycoprotein column. J Chromatogr (1990) 0.86
Leishmania major parasites express cyclophilin isoforms with an unusual interaction with calcineurin. Biochem J (1998) 0.86
Autoradiographic methods for the evaluation of ulcerogenic effects of anti-inflammatory drugs. Pharmacol Ther B (1979) 0.85
Adverse drug reactions in patients with gastroenterological diseases: does age increase the risk? Aliment Pharmacol Ther (2001) 0.85
Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief. Eur J Pain (2011) 0.85
Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study. J Neurochem (2000) 0.85
Interleukin-8 is a cyclosporin A binding protein. Experientia (1993) 0.85
Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience (2000) 0.85
Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly. Eur J Pharmacol (1986) 0.84
Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs. Arch Toxicol (1987) 0.84
Cyclophilin-A is a zinc-dependent DNA binding protein in macrophages. FEBS Lett (1995) 0.84
Stereoselectivity of biliary excretion of 2-arylpropionates in rats. Chirality (1993) 0.84
Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Handb Exp Pharmacol (2007) 0.84
Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects. Br J Clin Pharmacol (1995) 0.84
Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J (2001) 0.84
Rapid onset of hematotoxic effects after interferon alpha in hepatitis C. J Hepatol (2000) 0.83
Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body. Exp Eye Res (2001) 0.83
Autoradiographic and biochemical observations on the distribution of non-steroid anti-inflammatory drugs. Arch Int Pharmacodyn Ther (1981) 0.83
[Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migräne- und Kopfschmerz-Gesellschaft]. Schmerz (2000) 0.83
Genetics of the FANCA gene in familial pancreatic cancer. J Med Genet (2004) 0.82
A new reliable chemiluminescence immunoassay (CLIA) for prostaglandin E2 using enhanced luminol as substrate. Prostaglandins (1996) 0.82
An in vitro system for measuring endothelial permeability under hydrostatic pressure. Exp Cell Res (1983) 0.82
Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate. Br J Clin Pharmacol (2001) 0.82
Inhibition of prostaglandin synthesis in vivo by nonsteroid anti-inflammatory drugs: evidence for the importance of pharmacokinetics. Agents Actions (1976) 0.81
S-ibuprofen versus ibuprofen-racemate. A randomized double-blind study in patients with rheumatoid arthritis. Rheumatol Int (1991) 0.81
Distribution of extracellular matrix proteins in indomethacin-induced lesions in the rat stomach. Scand J Gastroenterol (1995) 0.81
Host-cell cyclophilin is important for the intracellular replication of Leishmania major. Mol Microbiol (1997) 0.81
Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages. Pharm Res (2001) 0.81
R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochem Biophys Res Commun (2001) 0.81